FOSTER CITY, Calif., Sept. 18, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a hematology-focused biopharmaceutical company pursuing more meaningful moments for people living with blood cancer, today reported that, effective September 17, 2026, it granted stock options to purchase an aggregate of 821,250 shares of common stock to nine newly hired employees as an inducement material to such employees’ acceptance of employment with Geron. The stock options have an exercise price of

SAN CARLOS, Calif., Sept. 18, 2026 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (“TIL”) therapies for patients with cancer, today announced that on September 17, 2026 (the “Date of Grant”), the Company approved the grant of inducement stock options covering an aggregate of 179,750 shares of Iovance’s common stock to eighteen

Anthropic launched a programme on Thursday designed to give life science researchers access to AI models that were previously unavailable for biology-related work, given the possibility that the technology could be abused for weapons development. The Life Sciences Verification Program (LSVP) makes Anthropic's Mythos, Opus and Sonnet models — with built-in safeguards — available to academic labs, pharmas and biotechs for research purposes that are blocked in its general Fable model, launched in J

A single-celled organism can shrink to one-quarter of its length in milliseconds using a remarkable calcium-powered protein “fishnet.” Scientists hope its unusual machinery could inspire artificial muscles capable of moving far faster than today’s designs.A tiny aquatic organism made of just one cell can compress its body to one quarter of its original length in under five milliseconds, hundreds of times faster than a person can blink. Scientists have now identified the unusual mechanism behind

Researchers have uncovered a hidden molecular warning sign of inflammatory bowel disease (IBD) that can linger even when patients feel well and appear to be in remission. By studying around 900 human gut biopsies and patient-derived mini-intestines, the team found that intestinal cells can remain unusually primed to die, creating a “smoldering” defect that may help drive future flare-ups.Researchers have identified early molecular warning signs of inflammatory bowel disease that may appear befor

Scientists have identified the genetic cause behind the mysterious AnWj blood group antigen, solving a puzzle that began in 1972 and establishing a new blood group system called MAL. The discovery could make it much easier to find extremely rare AnWj-negative patients and donors and protect them from potentially dangerous transfusion reactions.More than half a century after scientists first encountered a mysterious marker on human red blood cells, researchers finally traced it to its genetic sou

A chemical that stops drywood termites from building new exoskeletons killed about 95% of colonies in testing, offering a potentially safer alternative to traditional fumigation. Because termites eventually have no choice but to molt, the treatment turns a normal stage of their life cycle into a fatal weakness.Drywood termites are remarkably good at disappearing into the very material they destroy. Instead of building obvious nests, they can spend nearly their entire lives hidden inside beams, f

Novo Nordisk is now called Novo, with the change happening alongside new brand colours. Credit: Novo The top stories in healthcare this week include Novo's new brand identity, WHO's new envoy for health resilience and PwC's female fertility care research Meet Novo: Novo Nordisk’s New Brand Identity Novo Nordisk has announced it will remove 'Nordisk' from its company name. The change ends a naming convention that has existed for almost 40 years, following the 1989 merger of Nordisk Insulinlaborat

A growing Bundibugyo virus outbreak is showing how a little-known relative of Ebola can become a major threat when diagnosis and treatment options are limited. Experts warn that preparing only for familiar pathogens could leave the world vulnerable when rare but deadly viruses suddenly reemerge.A growing outbreak of the rare Bundibugyo virus in the Democratic Republic of Congo is drawing attention to a broader problem in global health: how to prepare for dangerous diseases that appear only rarel

A deep-sea microbe uses an exceptionally heat-resistant enzyme to turn atmospheric nitrogen into ammonia at temperatures that would destroy most proteins. Its unusual structure and a newly observed reaction state may reveal an ancient, shared mechanism behind nitrogen fixation and could eventually inspire cleaner biotechnology and fertilizer production.Microorganisms are capable of some extraordinary chemistry. One example is nitrogen fixation, a process that converts nitrogen gas (N2) into a fo